PHL89593

Camptothecin

phyproof® Reference Substance

Manufacturer: Sigma Aldrich

CAS Number: 7689-03-4

Synonym(S): (S)-(+)-Camptothecin

Select a Size

Pack Size SKU Availability Price
50 MG PHL89593-50-MG In Stock ₹ 34,455.98

PHL89593 - 50 MG

₹ 34,455.98

In Stock

Quantity

1

Base Price: ₹ 34,455.98

GST (18%): ₹ 6,202.076

Total Price: ₹ 40,658.056

grade

primary reference standard

product line

phyproof® Reference Substance

Assay

≥90.0% (HPLC)

form

powder

manufacturer/tradename

PhytoLab

mp

260 °C (dec.) (lit.)

storage temp.

2-8°C

SMILES string

CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5ccccc5nc34)C2=O

InChI

1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1

InChI key

VSJKWCGYPAHWDS-FQEVSTJZSA-N

Related Products

Img

Supelco

V-060

1 mg/mL in ethanol, certified refer...

Img

Sigma Aldrich

BP1109

British Pharmacopoeia (BP) Referenc...

Img

Supelco

181676

analytical standard, molecular weig...

Img

Sigma Aldrich

PHL89383

phyproof® Reference Substance...

Img

Sigma Aldrich

PHL89905

phyproof® Reference Substance...

Img

Supelco

A-119

1.0 mg/mL (50:50 Methanol/Water wit...

Img

Supelco

V-069

500 μg/mL (80:20 Water:Acetonitrile...

Img

Sigma Aldrich

PHL89251

phyproof® Reference Substance...

Description

  • General description: This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG
  • Application: Co-delivery system for camptothecin and doxorubicin: Research on dendritic polymer prodrug-based unimolecular micelles demonstrated a pH-responsive co-delivery mechanism for camptothecin and doxorubicin, offering a synergistic effect in controlled drug release (Chen and Liu, 2024).Investigation into camptothecin′s role in chronic myeloid leukemia: The study explored the therapeutic potential of FL118, a camptothecin derivative, against chronic myeloid leukemia resistant to BCR-ABL inhibitors, targeting RNA helicase DDX5 (Takeda et al., 2024).
  • Legal Information: phyproof is a registered trademark of PhytoLab GmbH & Co. KG

SAFETY INFORMATION

Pictograms

GHS06,GHS08

Signal Word

Danger

Hazard Statements

H301,H340

Precautionary Statements

P202 - P264 - P270 - P280 - P301 + P310 - P405

Hazard Classifications

Acute Tox. 3 Oral - Muta. 1B

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable